Healthways Inc. (NASDAQ:HWAY) traded down 2.4% during mid-day trading on Thursday . The company traded as low as $11.78 and last traded at $11.79, with a volume of 194,217 shares changing hands. The stock had previously closed at $12.08.

A number of equities research analysts have issued reports on the stock. Zacks Investment Research raised shares of Healthways from a “sell” rating to a “hold” rating in a report on Tuesday, May 3rd. Barrington Research reissued a “buy” rating on shares of Healthways in a report on Saturday, April 30th. Jefferies Group reissued a “hold” rating and set a $13.00 target price on shares of Healthways in a report on Tuesday, May 3rd. Finally, FBR & Co reissued a “buy” rating on shares of Healthways in a report on Friday, April 29th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and two have issued a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average target price of $13.40.

The stock’s market cap is $426.09 million. The firm has a 50-day moving average of $12.06 and a 200-day moving average of $11.54.

Healthways (NASDAQ:HWAY) last released its quarterly earnings results on Thursday, April 28th. The company reported ($0.08) EPS for the quarter, missing analysts’ consensus estimates of ($0.02) by $0.06. The company had revenue of $189.20 million for the quarter, compared to analysts’ expectations of $185.68 million. During the same period in the previous year, the company posted ($0.05) earnings per share. The company’s revenue for the quarter was down .4% compared to the same quarter last year. Equities analysts expect that Healthways Inc. will post $0.24 EPS for the current year.

Other institutional investors have recently added to or reduced their stakes in the company. BNP Paribas Arbitrage SA boosted its position in Healthways by 37.1% in the fourth quarter. BNP Paribas Arbitrage SA now owns 80,127 shares of the company’s stock worth $1,031,000 after buying an additional 21,702 shares in the last quarter. Royce & Associates LLC boosted its position in Healthways by 25.2% in the fourth quarter. Royce & Associates LLC now owns 796,704 shares of the company’s stock worth $10,254,000 after buying an additional 160,500 shares in the last quarter. Finally, American Capital Management Inc. boosted its position in Healthways by 4.0% in the fourth quarter. American Capital Management Inc. now owns 896,380 shares of the company’s stock worth $11,536,000 after buying an additional 34,590 shares in the last quarter.

Healthways, Inc (Healthways) provides network delivered solutions and population health management services that are designed to help people manage their wellbeing, thereby managing their health and productivity, and their health-related costs. The Company operates in the domestic and international segments, which are collectively known as the well-being improvement services segment.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.